Correlation Between FORMPIPE SOFTWARE and Vertex Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both FORMPIPE SOFTWARE and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FORMPIPE SOFTWARE and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FORMPIPE SOFTWARE AB and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on FORMPIPE SOFTWARE and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FORMPIPE SOFTWARE with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of FORMPIPE SOFTWARE and Vertex Pharmaceuticals.

Diversification Opportunities for FORMPIPE SOFTWARE and Vertex Pharmaceuticals

-0.45

Correlation Coefficient

FORMPIPE SOFTWARE  Vertex Pharmaceuticals

Very good diversification

The 3 months correlation between FORMPIPE and Vertex is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding FORMPIPE SOFTWARE AB and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and FORMPIPE SOFTWARE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FORMPIPE SOFTWARE AB are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of FORMPIPE SOFTWARE i.e., FORMPIPE SOFTWARE and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between FORMPIPE SOFTWARE and Vertex Pharmaceuticals

Assuming the 90 days horizon FORMPIPE SOFTWARE AB is expected to generate 1.13 times more return on investment than Vertex Pharmaceuticals. However, FORMPIPE SOFTWARE is 1.13 times more volatile than Vertex Pharmaceuticals Incorporated. It trades about 0.03 of its potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about -0.03 per unit of risk. If you would invest  231.00  in FORMPIPE SOFTWARE AB on April 21, 2025 and sell it today you would earn a total of  6.00  from holding FORMPIPE SOFTWARE AB or generate 2.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

FORMPIPE SOFTWARE AB  vs.  Vertex Pharmaceuticals Incorpo

FORMPIPE SOFTWARE

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in FORMPIPE SOFTWARE AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, FORMPIPE SOFTWARE is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Vertex Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vertex Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with FORMPIPE SOFTWARE and Vertex Pharmaceuticals

The main advantage of trading using opposite FORMPIPE SOFTWARE and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FORMPIPE SOFTWARE position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.

The idea behind FORMPIPE SOFTWARE AB and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.